Brodalumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Brodalumab has been used in trials studying the treatment of Asthma, Psoriasis, Crohn's Disease, Psoriatic Arthritis, and Rheumatoid Arthritis. Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.

Brodalumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Brodalumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32002	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9806	58
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1565	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10351	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24649	58
Biolab Reagents	027-65279366 18162686757	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5787	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	+86-18521732826	market@aladdin-e.com	China	48461	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	313359644@qq.com	China	3263	58

---

• Brodalumab
• Research Grade Brodalumab(DHJ38901)
• Brodalumab (anti-IL17RA)
• LP 0160|||KHK-4827|||AMG-827
• 1174395-19-7